Why do you like Andon Health + Gongniu Group, Xin Wu (Banyan)?
Jul 9, 2024
auto_awesome
Xin Wu, a top Chinese public equity investor, shares insights on investing in China, value investing opportunities, data availability, finding good companies, portfolio structure, shorting for value, and highlights on Gongniu Group and Andon Health.
Chinese equity market offers low valuations, creating opportunities for investors.
Gongniu Group shows growth potential with dominant market share in China.
Deep dives
China Equity Market Valuation and Opportunities
Valuation in the Chinese equity market is currently at its lowest in a 13-14 year period, presenting opportunities for investors. Companies like Gongyu are attractively priced, offering growth potential of 15-20%. Conversely, there are overvalued companies with flawed business models. This market condition provides a fertile ground for both long and short investments.
Gongyu: Category Killer and Growth Potential
Gongyu, a dominant brand in China, initially excelled in the extension cord market and later diversified into switches and EV chargers. With a market share exceeding 60% in online sales, Gongyu demonstrates consistent growth and market leadership. Its expansion into new segments, such as EV chargers, signals future potential and opportunity for investors.
Undone Health: COVID Response and Value Investing
Undone Health, a socially responsible company, pivoted during the COVID-19 pandemic by developing FDA-approved testing kits, resulting in substantial profits. While their core products are conventional medical devices, the swift action and market relevance during the pandemic highlight their adaptability and potential for value investing.
Investment Strategy and Criteria
The investment strategy focuses on value-based opportunities, employing equity long-short positions and thorough due diligence. Companies like Gongyu and Undone Health are evaluated based on growth, profitability, and return on capital. Catalysts, conservative management practices, and potential risks are key factors in determining investment entry and exit points.
Xin Wu of Banyan Partners (http://www.banyanpartners.cn/) is in the 10% of Chinese public equity’s investors, but not many know of him. Therefore, we were especially happy to welcome him on the podcast!
We have discussed the following: 00:00 Preview 00:52 Introducing Xin 01:27 Investing in China now compared to the past years 02:15 Why China is paradise for value investors currently 06:55 Data availability today 10:11 How to make money in a market like China 16:20 Observations on the market 20:57 Finding a good company 26:38 Criteria to build on an idea 28:40 Portfolio structure 30:33 Value through shorting 36:10 Gongniu Group 45:27 Join GI Plus 45:50 When to sell 48:33 Andon Health 56:22 Dealing with competence 01:00:34 Closing thoughts 01:01:43 Goodbye 01:02:00 Disclaimer
Join Good Investing Plus Apply here to Plus: https://good-investing.net/plus/
Our newsletter Subscribe to our newsletter: https://www.good-investing.net/contact/good-investing-center-newsletter-subscription/
Helpful tools for investors Stratosphere – beautiful stock analysis tool* – https://stratosphere.io/?lmref=bJ0jjw TIKR – great data tool *: https://tikr.com/goodinvesting/ Wise – our recommended savings account *: https://good-investing.net/wise/
Transparency Good Investing Talks is a video & audio production of Good Investing, a brand of Good Investing UG. The editorial responsibility of these broadcasts lies solely with Good Investing UG. In the run-up to the recording, the guests refrain from co-determination of content or editorial influence and pay a cost contribution for the organization and production of the video & audio and transcript formats. Disclaimer: https://good-investing.net/imprint/disclaimer/